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Letter to the Editor
Seroepidemiology of hepatitis E virus in Western Iran 
Dear Editor,
Hepatitis E is transmitted through water and contaminated 
food, and the clinical presentation can vary from an 
asymptomatic infection to a fulminant disease. The results 
of seroepidemiological studies revealed a 10% to 35% 
prevalence rate in developing countries. Hepatitis E has 
been considered the most prevalent cause of acute hepatitis 
in adults in Asia, and the second cause (after hepatitis 
B) in the Middle East.1 Several studies in Iran show a 
seroprevalence of 7% to 12%.2 Considering its transmission 
through contaminated water, and its epidemic history in 
Western Iran,3 studying the prevalence of hepatitis E 
in Khorramabad (Western Iran) seems appropriate, because 
the results of such a study can aid future health programs 
in this city.
This cross-sectional study was conducted during four 
months in 2009. It included subjects above 20 years of 
age, with a mean age of 36 years. A multiphase sampling 
method was applied and 400 subjects were selected from 
19 active health centers (226 females and 174 males). Out 
of 400 subjects, 31 cases, including 17 females (7.5%) and 14 
males (8%) were positive for hepatitis E virus (HEV), showing 
an overall prevalence rate of 7.8%. However, no significant 
difference was observed between these groups, the same as 
found in Tehran and Tabriz.2
The mean age of the HEV-negative subjects (369 cases) 
was 34.8 year, and that of infected cases (31 cases) was 
49.7 years. The highest HEV infection rate was found in the 
40-59 age group (61.25%). Sixteen cases (4%) reported a blood 
transfusion history, out of whom three (18.8%) were HEV-
positive. Fisher’s exact test did not show any significant 
relationship between the two variables (p = 0.118).
A direct relationship was found between an increase in 
age and infection rate in this study, the same as found in a 
study on the overall population of Iran;2 therefore, the 40-59 
age group should be specifically examined in subsequent 
similar laboratory and clinical studies.
Since the lowest availability to pure water has been 
reported in Lorestan,2 and due to the history of epidemics 
of the disease in the neighboring province of Kermanshah3 
and in the city of Shahre Kurd,4 possible outbreaks must 
be considered and necessary instructions and preventive 
measures have to be provided.
Moreover, since the major mode of transmission is fecal-
oral, it is necessary to promote hygiene, and appropriate 
hygienic sewage disposal in cities is the first priority. 
This present study was conducted in an urban area 
that has a better sewage disposal system than rural 
areas. Therefore, it is estimated that the prevalence in the 
whole province may be even higher. Consequently, it is 
recommended that studies should be performed in the rural 
areas of the province and the country as a whole to examine 
water sources for HEV infection.
In addition, studies have shown that HEV transmission is 
possible through blood transfusion. More studies are needed 
to confirm this fact. 
Routine examination of icteric and patients with hepatic 
diseases is recommended to prevent the virus from 
spreading to others, particularly pregnant women, due to 
high lethality; secondary preventive methods including 
vaccination should be sought along with primary preventive 
measures.5
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